NCT04854538: Bioequivalence Study of Budesonide From Ekmasonid 9 mg Extended Release FCT (Hikma Pharma, Egypt) Versus Uceris 9 mg Extended Release Tablets (Man. for: Salix Pharm., a Division of Valeant Pharm. LLC, USA, by: Cosmo S.P.A., Italy by License of Cosmo Tech. Ltd., Ireland, Product of France) |
|
|
| Completed | 1 | 30 | RoW | Ekmasonid, Uceris, Uceris (first dose), Uceris (second dose) | Genuine Research Center, Egypt, Hikma Pharmaceuticals LLC | Healthy | 10/20 | 12/20 | | |